Regeneron Pharmaceuticals
REGN
#153
Rank
$90.60 B
Marketcap
$834.64
Share price
1.19%
Change (1 day)
21.65%
Change (1 year)

Revenue for Regeneron Pharmaceuticals (REGN)

Revenue in 2023 (TTM): $12.67 B

According to Regeneron Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $12.67 B. In 2022 the company made a revenue of $12.17 B a decrease over the years 2021 revenue that were of $16.07 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regeneron Pharmaceuticals from 2001 to 2023

Annual revenue

Year Revenue Change
2023 (TTM)$12.67 B4.09%
2022$12.17 B-24.26%
2021$16.07 B89.14%
2020$8.49 B8.06%
2019$7.86 B17.18%
2018$6.71 B14.28%
2017$5.87 B20.82%
2016$4.86 B18.44%
2015$4.10 B45.55%
2014$2.81 B33.96%
2013$2.10 B52.69%
2012$1.37 B209.2%
2011$0.44 B-2.89%
2010$0.45 B21.04%
2009$0.37 B59.05%
2008$0.23 B90.73%
2007$0.12 B97.05%
2006$63.44 M-4.15%
2005$66.19 M-61.96%
2004$0.17 B193.29%
2003$59.33 M169.84%
2002$21.98 M-11.14%
2001$24.74 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$93.76 B 639.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$53.07 B 318.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$26.58 B 109.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$48.63 B 283.86%๐Ÿ‡ซ๐Ÿ‡ท France
$9.97 B-21.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.23 B-90.23%๐Ÿ‡บ๐Ÿ‡ธ USA